The U.S. Department of Veterans Affairs (VA) Veterans Health Administration has awarded a single-award indefinite delivery contract to Pharmalogic Syracuse, LLC, a for-profit limited liability company, to provide radiopharmaceuticals to the Albany VA Medical Center Nuclear Medicine department. The contract has a ceiling value of $3,800,294.96 and covers a base year plus four option years from April 1, 2024 through March 31, 2029.
Pharmalogic Syracuse, LLC will be required to provide a wide range of radiopharmaceutical products for various nuclear medicine procedures, including technetium, iodine, thallium, and gallium compounds. The contractor will also provide radiopharmaceuticals for specialized procedures such as WBC labeling, cardiac imaging, and therapy. The contract was awarded without any set-aside designations, and the place of performance is the Albany VA Medical Center in New York. The VA has also issued a firm-fixed-price delivery order under this contract with a value of $153,966.42 and a period of performance through March 31, 2025.
Generated 6/28/24, 9:07 AM